English
Français
Deutsch
Italiano
Polski
Português
Русский
Español
ไทย
Türkçe
简体中文
हिन्दी
日本語
Danaher
reported third-quarter earnings and revenue that topped Wall Street estimates on Tuesday.
Danaher
(ticker: DHR) reported earnings for the third quarter ended Sept. 29, of $2.02 a share on revenue of $6.87 billion. That beat analyst estimates of $1.81 a share on revenue of $6.6 billion.
In the same period last year, the company reported earnings of $2.56 a share on revenue of $7.66 billion.
“Revenue in the third quarter came in ahead of our expectations, with biotechnology performing as anticipated, and higher respiratory testing revenue more than offsetting slightly softer-than-anticipated demand in life sciences,” Chief Executive Rainer Blair said in a news release.
Danaher
also said for the full year, it anticipates that non-GAAP base business core revenue from continuing operations will be down slightly year over year.
Danaher shares were down 2.2% to $199.67. The stock has dropped 15% this year.
Write to Angela Palumbo at [email protected]
Read the full article here
